The UK is home to several biotech hubs and is a major player when it comes to Biotech innovation. In fact, after a £800 million surge in funding in the third quarter of 2023, the UK biotech scene is now one of the most vibrant in Europe. COVID-19 vaccine success stories like the Pfizer and BioNTech partnership helped highlight the biotech industry’s significant impact in advancing healthcare.
Private and public biotech funding helped the global biotech sector outperform its sister industry, pharmaceuticals, and the consumer goods and technology sectors. And despite a brief downturn at the start of 2020, the average growth in UK biotechs’ share price was 32%, surpassing European biotechs (22%) and US biotechs (2%).
In May 2023, the UK government announced a package called ‘Life Sci for Growth’, in which £650 million would be invested to boost the Life Sciences sector. The package also included plans to relaunch the Academic Health Science Network as Health Innovation Networks to boost innovation by bringing together the NHS, local communities, charities, academia, and industry to share best practices.
In February of this year, The Science and Tech Secretary unveiled a raft of new announcements to drive innovation in science. The UK Government released a statement stating the importance of the UK’s mission to be a science and technology superpower and plans to invest £100 million to biotech projects across the UK to help pioneer new technologies.
New funding initiatives within UK biotechnology projects
Announcements published in the February 2024 statement include:
- The UK Biobank has been given the cash injection for a new robotic freezer, which will be used to store 20 million samples of biological data - further supporting research that is being used to treat diseases like dementia and Parkinson’s.
- Announcing the winners of the Research Ventures Catalyst seed funding– with up to £100,000 available for organisations finding new and innovative ways to fund world-class R&D in the UK.
- Updating the Science and Technology Framework – outlining progress since the launch of the Framework last year - showing the government is providing record levels of funding to R&D in the UK with over £19.4 billion in the past year, supporting top researchers to spread the benefits of innovation - more jobs, opportunities, prosperity – across the country.
- Publishing two UK-led G7 papers on R&D common values and best practices - showing again the UK’s global leadership in the science and tech world and ensuring research is being conducted in a way that protects, rather than undermines, national security.
- Launching a £3 million metascience grant funding call – aimed at boosting the efficiency and effectiveness of the UK’s already world-leading research system.
- Launching an interactive innovation clusters map - offering a comprehensive picture of innovation activity in the UK aimed at helping policymakers and investors to better understand, engage with and invest in the UK’s vibrant innovation ecosystem.
Source: Biotech driving medical breakthroughs and cuts to red tape lead major science and tech package to spark UK innovation and growth
The measures will build on the record £19.4 billion invested in research and this year alone, the highest level this country has ever seen, and the nearly three quarter of a million jobs the sector has created in the last decade (a 41% increase).
Science and Technology Secretary Michelle Donelan said:
“Long term growth is the only way we will deliver the public services and improvements in living standards that every Briton wants for themselves and their families.
But as history shows, it is technological and scientific advances that are the true engine room of growth, and despite our existing strengths in these sectors, we cannot afford to pat ourselves on our back and take our eye off the ball.
Cementing the UK as a Science and Technology superpower by 2030 is more than a slogan. It is a goal we must reach if we want to grow our economy, continue creating well-paid jobs and build a better, healthier, more prosperous future for the UK.”
The UK government provides support for the biotechnology sector through various funding initiatives, grants, and tax incentives aimed at promoting research and development, technology transfer, and commercialisation. Organisations such as Innovate UK, the Biotechnology and Biological Sciences Research Council (BBSRC), and the UK Research and Innovation (UKRI) support biotech innovation and entrepreneurship.
Grassroots innovation within education
Some of the most recognisable names in UK biotech, including Oxford Biomedica (OXB) and Immunocore, have their roots in universities. According to the Royal Academy of Engineering, some 309 pharmaceutical groups have been spun out of academic institutions, more than any other sector. Driving this is the 'research tools and reagents' sector, itself a life sciences specialism, with 279 spin-out companies.
Studying MSc Biotechnology in UK is a great choice for those looking to pursue a career in the field. Biotechnologists in UK are contributing to advancements in pharmaceuticals and healthcare – as well as agriculture, biofuels, conservation, animal husbandry, and food production.
A growing sector within the recruitment space
Pharmaceutical roles within biotechnology span a wide range of roles and responsibilities, covering areas such as Research and Development, Manufacturing, Quality Assurance, Regulatory Affairs and Sales/Marketing. Common job titles within the field of healthcare biotechnology are as follows:
- Research Scientist
- Bioprocess Engineer
- Quality Control/Assurance Specialist
- Regulatory Affairs Specialist
- Bioinformatics Scientist
- Clinical Research Associate
- Sales/Marketing Representative
- Manufacturing Technician
- Product Development Manager
- Environmental Scientist
A rapidly evolving landscape of Biotechnology
These roles support the diverse and rapidly evolving landscape of Biotechnology within the UK, improving the lives of patients and innovating within the following advancements:
CRISPR Technology: CRISPR-Cas9 technology revolutionised gene editing, enabling precise modifications to DNA. Continuous advancements in CRISPR technology, such as base editing and prime editing, are expanding its applications in therapeutics, agriculture, and industrial biotechnology.
Synthetic Biology: Synthetic biology involves engineering biological systems for various applications. It's gaining momentum in fields like pharmaceuticals, biofuels, and biomaterials. Customised organisms are designed to produce valuable compounds, enzymes, and materials.
Personalised Medicine: Advances in genomics and biotechnology are driving the shift towards personalised medicine. Tailored treatments based on an individual's genetic makeup offer more effective and targeted therapies for diseases such as cancer and genetic disorders.
Immunotherapy: Immunotherapy utilises the body's immune system to combat diseases like cancer. Techniques like CAR-T cell therapy, checkpoint inhibitors, and therapeutic vaccines are at the forefront of cancer treatment research, showing promising results in clinical trials.
Biopharmaceuticals: Biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines, continue to dominate the pharmaceutical industry. Biotechnological advancements in protein engineering, expression systems, and manufacturing processes are improving their efficiency and reducing production costs.
Microbiome Research: The human microbiome, consisting of trillions of microbes inhabiting the body, plays a crucial role in health and disease. Biotechnological research is exploring the therapeutic potential of manipulating the microbiome to treat conditions ranging from gastrointestinal disorders to neurological diseases.
AI and Big Data in Biotech: Artificial intelligence (AI) and big data analytics are transforming biotechnology research and development. Machine learning algorithms analyse vast biological datasets to discover novel drug targets, predict protein structures, and optimise drug design processes.
Gene Therapy: Gene therapy holds promise for treating genetic disorders by delivering therapeutic genes into patients' cells. Recent advancements, such as improved delivery methods and viral vectors, are making gene therapy safer and more effective.
In an ever changing industry, Carrot Recruitment are committed to helping our clients find the best talent to drive biotechnology advancements forward. As breakthroughs continue to emerge, we are excited to be at the forefront of this dynamic industry and to support the development of life-changing products and therapies.
Are you looking for new talent?
Carrot specialise solely in Pharma, Biotech, and MedTech – our expertise spans numerous skills functions within these industries. We support clients in the contingent recruitment of mid to senior-level talent, both permanent and interim.
Since our inception 18 years ago, we’ve partnered with thousands of clients, helping grow their teams utilising both contract and permanent hiring solutions.
Looking for a new role?
We will fully prepare you for each stage of the recruitment process - from applying, to accepting an offer. We provide guidance and support with CV advice, interview tips and insider knowledge to give you more confidence about the workplace you’re entering and what the culture is like. We can also give you access to jobs that are confidentially advertised or not yet posted on the internet. With more options to apply to, you have a better chance of receiving the job offer you're looking for.
You can check out all the current vacancies we have available via our pharma jobs page
